Zhou Wenwen, Chen Huying, Hong Xiuli, Niu Xiaoqing, Lu Quanyi
Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361000, P.R. China.
Oncol Lett. 2014 Nov;8(5):2130-2134. doi: 10.3892/ol.2014.2481. Epub 2014 Aug 26.
DNA methyltransferases (including DNMT1, DNMT3A and DNMT3B), catalyze the transfer of methyl groups from S-adenosyl-l-methionine to cytosine position 5; this methylation in promoter regions silences gene expression. In addition, DNMT1 plays a critical role in the maintenance of genomic DNA methylation during DNA replication. In the present study, silencing of with siRNA was performed in RPMI-8226 human multiple myeloma (MM) cells, and the impact on gene methylation status and proliferation of the cells was analyzed. Upon downregulation, proliferation decreased significantly compared with that in the control, non-transfected cells. The expression of B-cell lymphoma 2 and nuclear factor κB proteins was also significantly reduced. Furthermore, nested methylation-specific polymerase chain reaction revealed that methylation of the tumor suppressor genes, suppressor of cytokine signaling 1 and was significantly reduced upon DNMT1 knockdown. Our results suggest that silencing may be a promising strategy to consider during development of novel MM treatment strategies.
DNA甲基转移酶(包括DNMT1、DNMT3A和DNMT3B)催化甲基从S-腺苷-L-甲硫氨酸转移至胞嘧啶的第5位;启动子区域的这种甲基化会使基因表达沉默。此外,DNMT1在DNA复制过程中维持基因组DNA甲基化方面发挥着关键作用。在本研究中,我们在RPMI-8226人多发性骨髓瘤(MM)细胞中用小干扰RNA(siRNA)使DNMT1沉默,并分析了其对细胞基因甲基化状态和增殖的影响。与未转染的对照细胞相比,DNMT1下调后细胞增殖显著降低。B细胞淋巴瘤2和核因子κB蛋白的表达也显著降低。此外,巢式甲基化特异性聚合酶链反应显示,DNMT1敲低后,细胞因子信号传导抑制因子1和2等肿瘤抑制基因的甲基化显著降低。我们的结果表明,在开发新型MM治疗策略时,DNMT1沉默可能是一个值得考虑的有前景策略。